Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | +1.33% | +16.46% | -27.65% |
09/05 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.65% | 9.29Cr | |
+9.99% | 12TCr | |
+12.01% | 11TCr | |
-3.07% | 2.47TCr | |
-0.93% | 2.2TCr | |
-5.71% | 1.93TCr | |
-6.90% | 1.76TCr | |
-39.36% | 1.73TCr | |
+5.82% | 1.4TCr | |
+33.05% | 1.21TCr |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Craig-Hallum Starts Cue Biopharma at Buy with $28 Price Target